Impact of the COVID-19 pandemic on lung transplant patients and on a cohort of patients with rare lung disease: A single-center study.
Fiche publication
Date publication
mars 2024
Journal
Respiratory medicine and research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel, Pr OLLAND Anne
Tous les auteurs :
Hussein M, Gallais F, Dégot T, Hirschi S, Leroux J, Riou M, Stauder J, Falcoz PE, Olland A, Kessler R, Renaud-Picard B
Lien Pubmed
Résumé
Due to the COVID-19 pandemic, France underwent several lockdown periods during 2020. Our aim was to evaluate its clinical and social impact on lung transplant (LT) patients treated at Strasbourg University Hospital, by comparing three periods: first lockdown (T1: March-May 2020), end of the first lockdown (T2: May-October 2020), and second lockdown (T3: November-December 2020) and the incidence of COVID-19 infections. A cohort of patients with rare lung disease (RLD) was also studied during T2.
Mots clés
COVID-19, Lifestyle factors, Lung transplantation, Protective measures, Rare lung disease
Référence
Respir Med Res. 2024 03 14;85:101100